Pfizer to buy Biohaven for $11.8 billion, reveals the Financial Times
Tuesday, 10 May 2022, 2:22 pm
The venerable Financial Times this morning revealed that US pharma giant Pfizer is in the advanced stages of buying Biohaven, a US-listed firm that has been working on treatments for migraines. Below is the link:
https://www.ft.com/content/ea9bb9bc-b5ec-4278-ab42-1f5f14a1a76f..